Philips Partners with DiA Imaging Analysis

Royal Philips and DiA Imaging Analysis Ltd., a provider of AI-powered applications for ultrasound, have announced a strategic partnership* to deliver automated solutions to clinicians at the point-of-care.

Philips spotlights new solutions at ECR 2021

Royal Philips has announced its participation in the European Congress of Radiology (ECR) virtual event, March 3-7, 2021, where the company will feature new and enhanced diagnostic and interventional solutions that further expand its Radiology Workflow Suite, connecting data, technology and people across the imaging enterprise.

Epsilon Imaging Partners with Siemens Healthineers

Epsilon Imaging, a visualization and analysis software provider transforming cardiac diagnostic workflow with strain imaging, has announced a partnership with Siemens Healthineers, a leading developer of medical imaging and information management solutions, to offer syngo Dynamics users EchoInsight visualization and analysis with strain imaging.

iRad Announces a Distributorship Agreement with FUJIFILM Medical Systems

iRad, Innovative Radiology Equipment Sales and Services, LLC has announced a distributorship agreement with FUJIFILM Medical Services.

MITA Outlines Policy Priorities in Letter to Biden Administration

The Medical Imaging & Technology Alliance (MITA)The Medical Imaging & Technology Alliance (MITA) sent a letter to President Joseph Biden and his administration outlining key MITA policies priorities for 2021. The letter also underscored the indispensable role of medical imaging technologies in supporting improved public health outcomes and delivering care to the vulnerable and other patient populations.

“By supporting care pathways for screening, staging, evaluating, managing and effectively treating patients with numerous medical conditions, including COVID-19, our technologies are an essential component of the nation’s health care infrastructure,” said Patrick Hope, executive director of MITA. “As this letter makes clear, we are eager to partner with President Biden and his administration to leverage these technologies to ensure patients have ongoing access to safe and effective innovative medical imaging solutions.”

MITA outlined seven policy priorities for the new administration to consider, including:

  • Enabling patients to return to care quickly and safely by ensuring health care providers are adequately reimbursed for their services
  • Protecting patient safety by requiring third-party medical device servicing businesses to adhere to appropriate regulations, including registration with the Food and Drug Administration (FDA), filing Medical Device Reports (MDRs) and implementing quality management systems
  • Promoting patient access to innovative imaging technologies through improved transparency, accountability and predictability of the Medicare national coverage determination process, as well as adequate reimbursement to support health care provider adoption of these technologies
  • Recognizing the value of imaging drugs, including positron emission tomography (PET) and single-photon emission computerized tomography (SPECT) radiotracers, by removing barriers to appropriate Medicare coverage of these products and ensuring appropriate payment for their use
  • Supporting efficient, consistent and transparent FDA premarket review of medical imaging technologies via the Medical Device User Fee Agreement (MDUFA) V that maintains current performance levels and maintains appropriations as the majority share of FDA device program funding
  • Facilitating efficient, transparent and adequately staffed Veterans Affairs (VA) and Department of Defense (DoD) procurement of medical imaging technologies, ensuring veterans and service members have access to medically necessary imaging exams
  • Supporting the ongoing stability and resilience of the thoughtfully developed international medical device supply chain

Along with the letter, MITA also included several issue briefs and background materials on key policy areas, including medical device servicing; radiopharmaceutical and PET reimbursement; and policies that promote medical innovation, among other topics.

“The historic health and economic disruptions of the last year demand immediate, decisive action on a multitude of fronts, not only from our leaders in Washington but from the entire medical technology sector,” added Hope. “In this unpredictable environment, public and private collaboration will be crucial. We look forward to engaging with President Biden and his team to support innovators, providers, and American patients.”



Submit a Comment

Your email address will not be published. Required fields are marked *